106 related articles for article (PubMed ID: 27464947)
1. Assessment of Protein Binding of 5-Hydroxythalidomide Bioactivated in Humanized Mice with Human P450 3A-Chromosome or Hepatocytes by Two-Dimensional Electrophoresis/Accelerator Mass Spectrometry.
Yamazaki H; Suemizu H; Kazuki Y; Oofusa K; Kuribayashi S; Shimizu M; Ninomiya S; Horie T; Shibata N; Guengerich FP
Chem Res Toxicol; 2016 Aug; 29(8):1279-81. PubMed ID: 27464947
[TBL] [Abstract][Full Text] [Related]
2. Approach for in vivo protein binding of 5-n-butyl-pyrazolo[1,5-a]pyrimidine bioactivated in chimeric mice with humanized liver by two-dimensional electrophoresis with accelerator mass spectrometry.
Yamazaki H; Kuribayashi S; Inoue T; Tateno C; Nishikura Y; Oofusa K; Harada D; Naito S; Horie T; Ohta S
Chem Res Toxicol; 2010 Jan; 23(1):152-8. PubMed ID: 19928966
[TBL] [Abstract][Full Text] [Related]
3.
Uehara S; Murayama N; Higuchi Y; Shimizu M; Suemizu H; Guengerich FP; Yamazaki H
Chem Res Toxicol; 2024 May; 37(5):671-674. PubMed ID: 38626399
[TBL] [Abstract][Full Text] [Related]
4. In vivo formation of dihydroxylated and glutathione conjugate metabolites derived from thalidomide and 5-Hydroxythalidomide in humanized TK-NOG mice.
Yamazaki H; Suemizu H; Shimizu M; Igaya S; Shibata N; Nakamura M; Chowdhury G; Guengerich FP
Chem Res Toxicol; 2012 Feb; 25(2):274-6. PubMed ID: 22268628
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of primary oxidative metabolites of thalidomide in rats and in chimeric mice humanized with different human hepatocytes.
Miura T; Uehara S; Shimizu M; Suemizu H; Yamazaki H
J Toxicol Sci; 2021; 46(7):311-317. PubMed ID: 34193768
[TBL] [Abstract][Full Text] [Related]
6. Combining Chimeric Mice with Humanized Liver, Mass Spectrometry, and Physiologically-Based Pharmacokinetic Modeling in Toxicology.
Yamazaki H; Suemizu H; Mitsui M; Shimizu M; Guengerich FP
Chem Res Toxicol; 2016 Dec; 29(12):1903-1911. PubMed ID: 27337115
[TBL] [Abstract][Full Text] [Related]
7. Induction of human cytochrome P450 3A enzymes in cultured placental cells by thalidomide and relevance to bioactivation and toxicity.
Murayama N; Kazuki Y; Satoh D; Arata K; Harada T; Shibata N; Guengerich FP; Yamazaki H
J Toxicol Sci; 2017; 42(3):343-348. PubMed ID: 28496040
[TBL] [Abstract][Full Text] [Related]
8. Human cytochrome P450 oxidation of 5-hydroxythalidomide and pomalidomide, an amino analogue of thalidomide.
Chowdhury G; Shibata N; Yamazaki H; Guengerich FP
Chem Res Toxicol; 2014 Jan; 27(1):147-56. PubMed ID: 24350712
[TBL] [Abstract][Full Text] [Related]
9. Simulation of Human Plasma Concentrations of Thalidomide and Primary 5-Hydroxylated Metabolites Explored with Pharmacokinetic Data in Humanized TK-NOG Mice.
Nishiyama S; Suemizu H; Shibata N; Guengerich FP; Yamazaki H
Chem Res Toxicol; 2015 Nov; 28(11):2088-90. PubMed ID: 26492539
[TBL] [Abstract][Full Text] [Related]
10. Metabolic profiles of pomalidomide in human plasma simulated with pharmacokinetic data in control and humanized-liver mice.
Shimizu M; Suemizu H; Mitsui M; Shibata N; Guengerich FP; Yamazaki H
Xenobiotica; 2017 Oct; 47(10):844-848. PubMed ID: 27852146
[TBL] [Abstract][Full Text] [Related]
11. Validation of uPA/SCID mouse with humanized liver as a human liver model: protein quantification of transporters, cytochromes P450, and UDP-glucuronosyltransferases by LC-MS/MS.
Ohtsuki S; Kawakami H; Inoue T; Nakamura K; Tateno C; Katsukura Y; Obuchi W; Uchida Y; Kamiie J; Horie T; Terasaki T
Drug Metab Dispos; 2014 Jun; 42(6):1039-43. PubMed ID: 24711249
[TBL] [Abstract][Full Text] [Related]
12. In vivo drug interactions of the teratogen thalidomide with midazolam: heterotropic cooperativity of human cytochrome P450 in humanized TK-NOG mice.
Yamazaki H; Suemizu H; Murayama N; Utoh M; Shibata N; Nakamura M; Guengerich FP
Chem Res Toxicol; 2013 Mar; 26(3):486-9. PubMed ID: 23419139
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of primary metabolites 5-hydroxythalidomide and 5'-hydroxythalidomide formed after oral administration of thalidomide in the rabbit, a thalidomide-sensitive species.
Kuwagata M; Hasegawa T; Takashima H; Shimizu M; Kitajima S; Yamazaki H
J Toxicol Sci; 2021; 46(12):553-560. PubMed ID: 34853241
[TBL] [Abstract][Full Text] [Related]
14. In vivo formation of a glutathione conjugate derived from thalidomide in humanized uPA-NOG mice.
Yamazaki H; Suemizu H; Igaya S; Shimizu M; Shibata N; Nakamura M; Chowdhury G; Guengerich FP
Chem Res Toxicol; 2011 Mar; 24(3):287-9. PubMed ID: 21299192
[TBL] [Abstract][Full Text] [Related]
15. Species Specificity and Selection of Models for Drug Oxidations Mediated by Polymorphic Human Enzymes.
Yamazaki H; Shimizu M
Drug Metab Dispos; 2023 Jan; 51(1):123-129. PubMed ID: 35772770
[TBL] [Abstract][Full Text] [Related]
16. Expression of human cytochromes P450 in chimeric mice with humanized liver.
Katoh M; Matsui T; Nakajima M; Tateno C; Kataoka M; Soeno Y; Horie T; Iwasaki K; Yoshizato K; Yokoi T
Drug Metab Dispos; 2004 Dec; 32(12):1402-10. PubMed ID: 15383493
[TBL] [Abstract][Full Text] [Related]
17. [Viability and differentiation of human hepatocytes immunoprotected by macroencapsulation and transplanted in rats].
Nicoluzzi JE; Barbu V; Baudrimont M; Lakehal F; Becquemont L; Chafaï N; Delelo R; Sarkis R; Honiger J; Housset C; Balladur P
Gastroenterol Clin Biol; 2000 Mar; 24(3):342-8. PubMed ID: 10804344
[TBL] [Abstract][Full Text] [Related]
18. Chimeric mice with humanized liver.
Katoh M; Tateno C; Yoshizato K; Yokoi T
Toxicology; 2008 Apr; 246(1):9-17. PubMed ID: 18248870
[TBL] [Abstract][Full Text] [Related]
19. Metabolism of capsaicin by cytochrome P450 produces novel dehydrogenated metabolites and decreases cytotoxicity to lung and liver cells.
Reilly CA; Ehlhardt WJ; Jackson DA; Kulanthaivel P; Mutlib AE; Espina RJ; Moody DE; Crouch DJ; Yost GS
Chem Res Toxicol; 2003 Mar; 16(3):336-49. PubMed ID: 12641434
[TBL] [Abstract][Full Text] [Related]
20. Differences in Toxicological and Pharmacological Responses Mediated by Polymorphic Cytochromes P450 and Related Drug-Metabolizing Enzymes.
Yamazaki H
Chem Res Toxicol; 2017 Jan; 30(1):53-60. PubMed ID: 27750412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]